drugset / Trial / NCT02452112

Efficacy and Safety of 5% Lidocaine Patch With Placebo Patch in Subjects With Herpes Zoster Associated Pain

NCT02452112

Phase 2/3 Completed 243 enrolled Mundipharma (China) Pharmaceutical Co. Ltd
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of 5% lidocaine patch, following placebo or active patch applications in placebo insensitive subjects.

Timeline

Start
2014-11-02
Primary completion
2015-12-30
Completion
2016-10-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 5 %